PUBLIC CITIZEN for PUBLIC CITIZEN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2025 | $98,808 | Replaced |
| 2nd Quarter - Amendment | Jul 21, 2025 | $98,808 | Yes |
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
general banking issue, crypto legislation, Defense of CFPB, CRAs for overdraft, payments rule; stablecoin legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BARTLETT NAYLOR | — |
Budget/Appropriations BUD
FY 2025 appropriations, opposing policy riders in appropriations, budget reconciliations, opposition to budget resolution
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RENE BEAVERS | — |
| SUSAN ELAINE HARLEY | — |
Civil Rights/Civil Liberties CIV
Introduction Call - Rep. McIver, Rep Lieu re. access to justice, civil justice, Sen. Hickenlooper re. Product Safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTHA PEREZ-PEDEMONTI | — |
Consumer Issues/Safety/Products CSP
H.R. 277, H.R. 357, H.R. H.R. 288, H.R. 890, H.R. 7528, H.R. 7533, H.R. 788, H.R. 3446, H.R. 115, H.R. 358, H.R. 7198, H.R. 7867, H.R. 8033, H.R. 9030, H.R. 9031, H.R. 9032, H.R. 9033, H.R. 9085. Regulatory reform, Stop Corporate Capture Act (H.R. 1507), Corner Post Reversal Act (H.R. 9014). Stop Corporate Capture Act (H.R. 1507, S. 4749), Comment Integrity and Management Act of 2024 (H.R. 7528). artificial intelligence safeguards, Blumenthal - product safety updates. REINS Act (H.R. 277). Green Tape Elimination Act.GOOD Act, Guidance Clarity Act, SOPRA, Stop Corporate Capture Act, Corner Post Reversal Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTHA PEREZ-PEDEMONTI | — |
| ELIZABETH SKERRY | — |
Taxation/Internal Revenue Code TAX
Direct File, financial transaction tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
Government Issues GOV
Reauthorize Office of Congressional Ethics (OCE), Communications with Congressional staff about corporate lobbying disclosure, DC statehood, prohibiting congressional stock trading activity, Regulating Inaugural funding, Freedom of Information Act reform, ETHICS Act (HR 2678, S 1171), Inaugural Fund Integrity Act (HR 535), Campaign Finance Disclosure Legislation, Met with House Member staff to discuss. DISCLOSE Act. Presidential Conflict of Interest Act. Discussion about Campaign Finance Disclosure Policy Ideas. Communications with House staff re: potential campaign disclosure legislation, Drafting memo to House encouraging Campaign Disclosure legislation; Communications with House staff re: potential campaign disclosure legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN GOLINGER | — |
| SUSAN ELAINE HARLEY | — |
| CRAIG HOLMAN | — |
Health Issues HCR
H.R.3421 & S.1655 - Medicare for All, Health care nominations, Medicare Advantage
| Lobbyist | Covered position, as disclosed |
|---|---|
| EAGAN KEMP | — |
Labor Issues/Antitrust/Workplace LBR
heat stress, OSHA issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULEY FULCHER | — |
Pharmacy PHA
anti-obesity medication pricing, Medicare drug price negotiation, international reference price negotiation price caps, number of drugs negotiated, out of pocket caps, inflation rebates, negotiation delay periods, direct-to-consumer pharmaceutical telehealth, Capping Prescription Costs Act, HHS Secretary, Deputy HHS Secretary, and CMS nominations, orphan drug exemption and negotiation delay period.H.R. 946 Orphan CURES Act; Medicare drug price negotiation eligibility delay period, S.652 Protecting Patients from Deceptive Drug Ads Online Act, EPIC Act (H.R. 1492 / S. 832), ORPHAN Cures Act (H.R.946), and MINI Act (H.R.1672); Medicare drug price negotiation delay periods and exemptions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.